product image
Notizia

Feb 14, 2020

The pancreatic cancer drug of GlaxoSmithKline moves to phase 1 The experimental drug, GSK095 of GlaxoSmithKline is made to work in order with a checkpoint that are inhibiti...

Read More
product image
AZ dragout Entasis; Sierra remunerates Gilead; Principia raises; Harbour BioMed and Kelun pen deal

Jun 19, 2020

AstraZeneca dragout Entasis files to fund antibiotic phase 3 for USD 86 Million IPO Massachusetts-based Entasis Therapeutics has spun out to raise up to USD 86 Million thro...

Read More
product image
Antibody-Drug Conjugate Market Insight

Jun 26, 2020

DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Compe...

Read More
product image
PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016

Feb 14, 2020

DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA). DelveInsight Report, PD-1 an...

Read More
product image
PD-1 and PD-L1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2015

Feb 14, 2020

PD-1and PDL-1 are the next targeted agents in Oncology. These therapies have the enormous potential to treat cancer and have an excellent response in the increasing number ...

Read More